GlobeNewswire4d agoneutral
Edesa Biotech to Present at Guggenheim Healthcare Innovation ConferenceNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.72d agoneutral
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical CatalystsZacks Small Cap Research76d agoneutral
EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get UnderwaySimply Wall St.199d agobullish
Edesa Biotech Reaches US$68m Market Cap Benefiting Insider Stock BuyingInsider Monkey202d agoneutral
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo TreatmentSimply Wall St.376d agoneutral
Favourable Signals For Edesa Biotech: Numerous Insiders Acquired Stock